PKM and chronic pancreatitis: By combining three independent plasma sample cohorts, we identified significantly higher levels of autoantibodies against two exosome surface proteins (PKM2 and LGALSBP3) in early-stage PDAC patients compared to matched healthy subject and chronic pancreatitis controls.